Core Insights - Danone Nutricia's Wuxi factory expansion project has officially topped out, aiming to build multiple fully automated sterilization production lines to enhance the production capacity of enteral nutrition suspensions [1] Company Overview - Danone Nutricia Pharmaceutical (Wuxi) Co., Ltd. was established in 2000 and has developed a comprehensive product system covering enteral nutrition products and supporting medical devices in the Chinese market [1] - The Wuxi factory produces enteral nutrition formulations such as EnfaCare and Peptamen, as well as the Nutricia enteral nutrition infusion system, which serves various clinical fields including oncology, stroke, allergies, digestive system diseases, and elderly nutrition [1] Market Position - China is Danone's second-largest global market and a crucial driver for future growth [1] - The expansion of advanced medical nutrition production capacity in Wuxi will enable the company to provide more efficient and precise personalized medical nutrition solutions to consumers [1]